May you live in interesting times… A colleague flagged this for me. I’ll be very interested in the particulars of how this all works going forward. #ItsAllAboutApps
Source: Novartis goes digital with FocalView for ophthalmology clinical trials
I like seeing disruption in the technology sphere from the technology side rather than the regulatory side. It happened to be the Republicans on the regulatory side, but the Dems have their days too.